Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hormone Replacement Therapy
Biotech
Ascendis sells Japan rights to Skytrofa, 2 other drugs for $70M
Ascendis has pocketed $70 million in exchange for the Japanese rights to the FDA-approved Skytrofa and two other hormone drugs.
James Waldron
Nov 29, 2023 8:25am
FDA unexpectedly halts Ascendis' drug review
Apr 3, 2023 10:22am
Protagonist posts hormone replacement data in iron disease
Nov 15, 2021 9:25am
BIO: In conversation with Sabrina Johnson, CEO of Daré Bioscience
Jun 5, 2019 8:55am
Trial suggests KaNDy’s menopause drug better than HRT
Jun 7, 2018 8:52am
TherapeuticsMD refiles menopause drug
Nov 6, 2017 9:57am
